Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)

Respiratory Syncytial Virus infections are one of the leading causes of severe respiratory diseases that require hospitalization and, in some cases, intensive care. Once resolved, there may be respiratory sequelae of varying severity. The lack of effective treatments for bronchiolitis and the lack o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ital J Pediatr
Päätekijät: Bollani, Lina, Baraldi, Eugenio, Chirico, Gaetano, Dotta, Andrea, Lanari, Marcello, Del Vecchio, Antonello, Manzoni, Paolo, Boldrini, Antonio, Paolillo, Piermichele, Di Fabio, Sandra, Orfeo, Luigi, Stronati, Mauro, Romagnoli, Costantino
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Review
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4681171/
https://ncbi.nlm.nih.gov/pubmed/26670908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-015-0203-x
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia